August 2025 in “Therapeutics” Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.
June 2025 in “Current Issues in Molecular Biology” Meloside A may help protect hair cells from damage linked to hair loss.
January 2025 in “Cell Communication and Signaling” CXXC5 can both suppress and promote cancer, making it a complex target for treatment.
January 2025 in “Applied Sciences” Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.
December 2024 in “Journal of Investigative Dermatology” People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.
February 2024 in “Cancers” New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.
September 2023 in “Animals” Genes linked to wool fineness in sheep have been identified.
June 2023 in “BMC Pharmacology and Toxicology” The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.
February 2023 in “Vaccines” COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.
August 2022 in “IARS international research journal” The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.
May 2022 in “Liver transplantation” The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.
January 1999 in “Universitas Philosophica” Cornifin-alpha/SPRR1 is increased in certain skin conditions and by specific treatments.
March 2017 in “Zenodo (CERN European Organization for Nuclear Research)” L. plantarum MTCC 1325 may help improve memory and cognitive functions in Alzheimer's.
September 2023 in “Zenodo (CERN European Organization for Nuclear Research)” The document's conclusion cannot be determined because the content is not available.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” March 2022 in “Zenodo (CERN European Organization for Nuclear Research)” 
September 2014 in “Hair transplant forum international” I'm sorry, but there's no conclusion provided to summarize.
October 2022 in “Zenodo (CERN European Organization for Nuclear Research)” June 2020 in “Zenodo (CERN European Organization for Nuclear Research)” March 2023 in “Zenodo (CERN European Organization for Nuclear Research)” March 2023 in “Oxford University Press eBooks” November 2022 in “Zenodo (CERN European Organization for Nuclear Research)” January 2023 in “Zenodo (CERN European Organization for Nuclear Research)” 
September 1997 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
September 2021 in “Zenodo (CERN European Organization for Nuclear Research)” 
January 1997 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available for analysis.
July 2023 in “Zenodo (CERN European Organization for Nuclear Research)” 
June 2019 in “Reactions Weekly”